In 2008, Jay Lichter, Ph.D., a partner at Avalon Ventures and biotechnology industry veteran, experienced his first severe attack of vertigo. While driving, he became severely disoriented and had to pull to the side of the road. After multiple doctor visits, he was diagnosed with Ménière’s disease and quickly experienced the limitations of available treatments. With his physician, Jeffrey Harris, M.D., Ph.D., chief of the division of otolaryngology-head and neck surgery at the University of California, San Diego, and several other experts in the field of otology, Dr. Lichter founded Otonomy to bring new treatment options to patients with otic (ear) disorders.

Our mission today remains the same – to develop and commercialize novel and best-in-class therapeutics to address the significant unmet medical needs in the emerging otology market.

from http://www.otonomy.com/about-us/our-story/

Patents 232show all

  • 114
    A61K - Preparations for medical, dental, or toilet purposes
  • 14
    Y02A - Technologies for adaptation to climate change
  • 13
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 10
    C07K - Peptides
  • 5
    A61M - Devices for introducing media into, or onto, the body
  • 3
    C12N - Microorganisms or enzymes
  • 2
    A61B - Diagnosis
  • 2
    A61F - Filters implantable into blood vessels
  • 1
    A61N - Electrotherapy

Clinical Trials 28show all

16Phase 38Phase 22Phase 12Phase 1/Phase 2

SEC Filings show all


42
8-K

16
10-Q

5
10-K

2
D

1
S-1

Contact Information

6275 Nancy Ridge Drive,, Suite 100
San Diego, CA 92121
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$153,437,00051-1002014-04-30Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2010-06-11$10,000,000Series AAvalon Ventures
2013-09-04$45,900,000Series COrbiMedOUP (Osage University Partners), Aperture Venture Partners, Novo Ventures, RiverVest, Avalon Ventures, TPG Biotech, Domain Associates
2014-04-30$49,000,000Series DJennison Associates, Perceptive Advisors, OUP (Osage University Partners), Aperture Venture Partners, RiverVest, Domain Associates, Ally Bridge Group, TPG Biotech, Novo Ventures, OrbiMed, Avalon Ventures, Federated Investors
2010-09-02$10,037,000Series Unknown
2010-08-30$38,500,000Series BNovo Ventures, RiverVestDomain Associates, TPG Biotech

SEC Form D Funding Events

DateOfferedSoldType
2011-06-02$38,844,352$24,214,701Equity
2010-06-09$26,000,000$10,567,046Equity

Key Executives

  • Jay Lichter, Ph.D.
    Executive Officer, Director
  • Paul Cayer
    Executive Officer
  • Carl LeBel, Ph.D.
    Executive Officer
  • Douglas Downs
    Executive Officer
  • Court Turner
    Director
  • Jeffrey Harris, M.D., Ph.D.
    Director
  • David Weber
    Executive Officer, Director
  • Carl LeBel
    Executive Officer
  • Gerald Wroblewski
    Executive Officer
  • Peter Bisgaard
    Director
  • Brian Dovey
    Director
  • Jeffrey Harris
    Director
  • Jay Lichter
    Director
  • John McKearn
    Director
  • Heather Preston
    Director